ClinicalTrials.gg
Sign In

Dermatomyositis clinical trials

The registry lists 184 studies for Dermatomyositis across more than 10 countries. 63 are recruiting or about to start. 122 of them are mainly about Dermatomyositis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Dermatomyositis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
75
Recruiting
50
Status unknown
19
Terminated
14
Not yet recruiting
9
Active, not recruiting
8

Phase

Phase 2
61
Phase 3
31
Phase 1
29
Phase 4
9
Early Phase 1
5

Where

United States
94
China
31
France
31
Germany
22
Poland
20
Italy
20

Who runs them

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (8) · National Institute of Environmental Health Sciences (NIEHS) (6) · Chongqing Precision Biotech Co., Ltd (4) · University Hospital, Strasbourg, France (4) · Assistance Publique - Hôpitaux de Paris (4) · Karolinska Institutet (4) · The First Affiliated Hospital with Nanjing Medical University (4) · Pfizer (4)

What is being tested here

Drugs under test in Dermatomyositis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tocilizumab304
Dazukibart224
Tofacitinib203
Cyclophosphamide202
Fludarabine202
Abatacept104
Baricitinib113
Sodium thiosulfate113
Rituximab113
Infliximab113

Drug classes tested here JAK inhibitors 3 open · Tyrosine kinase inhibitors (TKIs) 3 open · Antimetabolites 3 open

Coming up

8phase 3 studies under way
10studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10

Who these studies take

Of the 50 Dermatomyositis studies recruiting now, 24 (48%) set no upper age limit and 16 (32%) stop at 75 or younger. 15 (30%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (12%) take healthy volunteers.

Recruiting studies that take each age, of 50
AgeWomenMen
1013 (26%)13 (26%)
1847 (94%)47 (94%)
3048 (96%)48 (96%)
4048 (96%)48 (96%)
5048 (96%)48 (96%)
6545 (90%)45 (90%)
7536 (72%)36 (72%)
8532 (64%)32 (64%)

Across all 184 studies, recruiting or not: 38% stop at 75 or younger and 21% at 65; 33% take children; 1% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dermatomyositis studies take

Of 19 phase 2 interventional studies under Dermatomyositis, half reached primary completion within 31 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 231 mo28–52 · 19 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 184. Browse all 184 → or search them.